Seminar by Dr. Brahmachary Enugurthi, Senior Director, Viking Therapeutics, Inc., USA on "Ozanimod: Drug Discovery and Development of a S1P1 and S1P5 Receptors Selective Agonist for the Treatment of Autoimmune Diseases"

14 Nov 2023
Seminar Room # 350, second floor annex

------------------------------------------------------------------------
Speaker: Dr. Brahmachary Enugurthi
Senior Director, Pharmaceutical Development and
Manufacturing Viking Therapeutics, Inc.
San Diego, California USA

Title: "Ozanimod: Drug Discovery and Development of a S1P1 and
S1P5 Receptors Selective Agonist for the Treatment of
Autoimmune Diseases".

Day and Date: Tuesday, November 14, 2023

Time: 11.00 am.

Venue: Seminar room, room no. 350,
Chemistry Department (second floor)
------------------------------------------------------------------------

Hosted by Prof. Sambasivarao Kotha

Talk Title : "Ozanimod: Drug Discovery and Development of a S1P1 and S1P5 Receptors Selective Agonist for the Treatment of Autoimmune Diseases"
Abstract
Ozanimod, is a selective modulator of S1P1 and S1P5 receptors approved for the treatment of autoimmune diseases such as multiple sclerosis (MS), ulcerative colitis (UC) and being evaluated for Crohn’s Disease (CD). Drug discovery, development and chemical synthesis of Ozanimod will be presented.